Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions

References

• AdamWRMeagherEJBarterCE1982Labetalol, beta blockers, and acute deterioration of chronic airway obstructionClin Exp Hypertens A41419286126285
   PubMed Web of Science ®Google Scholar
• AndersonGJariwallaAGAl-ZaibakM1980A comparison of oral metoprolol and propranolol in patients with chronic bronchitisJ Int Med Res813686989683
   PubMed Web of Science ®Google Scholar
• BeilMUlmerWT1977Effects of a new cardioselective betaadrenergic blocker (atenolol) on airway resistance in chronic obstructive diseaseArzneim-Florsch2741922324487
   PubMed Web of Science ®Google Scholar
• BelliGTopolEJ1995Adjunctive pharmacologic strategies for acute MIContemp Intern Med7519
   Google Scholar
• ButlandRJPangJAGeddesDM1983Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysemaJ Appl Physiol541368736863097
   PubMed Web of Science ®Google Scholar
• CamsariAArikanSCandanA2003Metoprolol, a β-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary diseaseHeart Vessels181889214520486
   PubMed Web of Science ®Google Scholar
• ChafinCCSobermanJEDemircanK1999Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma?Cardiology929910510702651
   PubMed Web of Science ®Google Scholar
• ChenJRedfordMJWangY2001Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patient with chronic obstructive airways disease or asthmaJ Am Coll Cardiol371950611401137
   PubMed Web of Science ®Google Scholar
• CraigTRichersonHBMoeckliJ1996Problem drugs for the patient with asthmaCompr Ther22339448814381
   PubMedGoogle Scholar
• DorowPBethgeHTönnesmannU1986Effects of single oral doses of bisobrolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectorisEur J Clin Pharmacol3114372879733
   PubMed Web of Science ®Google Scholar
• DorowPClauzelAMCaponeP1986A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstructionJ Cardiovasc Pharmacol8Suppl 4S1024
   PubMed Web of Science ®Google Scholar
• DoughtyRNRodgersASharpeN1997Effects of beta-blocker therapy on mortality in patients with heart failure A systematic overview of randomised controlled trialsEur Heart J1856059129883
   PubMed Web of Science ®Google Scholar
• EgredMShawSMohammadB2005Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary diseaseQ J Med984937
   Google Scholar
• FalliersCJVrchotaJBlasucciDJ1985The effects of treatment with labetolol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to probranololJ Clin Hypertens17093836297
   PubMedGoogle Scholar
• FensterPEHasanFMAbrahamT1983Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary diseaseClin Cardiol612596851273
   PubMed Web of Science ®Google Scholar
• FogariRZoppiATettamantiF1990Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung diseaseCardiovasc Drugs Ther4114591982059
   PubMed Web of Science ®Google Scholar
• FormgrenH1976The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmaticsBr J Clin Pharmacol3100714
   PubMed Web of Science ®Google Scholar
• FreemantleNClelandJYoungP1999Beta blockade after myocardial infarction: systematic review and meta regression analysisBr Med J3181730710381708
   PubMed Web of Science ®Google Scholar
• FrishmanWSilvermanRStormJ1979Clinical pharmacology of the new beta blocking drugs: part-4. Adverse effects: choosing a beta adrenoreceptor blockerAm Heart J982566236744
   PubMed Web of Science ®Google Scholar
• FrishmanWH1998Beta adrenergic receptor blockers: adverse effects and drug interactionHypertension11Suppl II11219
   Google Scholar
• FrishmanWHFurbergCDFriedewaldWT1984Beta-adrenergic blockade for survivors of acute myocardial infarctionN Engl J Med31083076142420
   PubMed Web of Science ®Google Scholar
• GeorgeRBManochaKBurfordJG1983Effects of labetalol in hypertensive patients with chronic obstructive pulmonary diseaseChest83457606337786
   PubMed Web of Science ®Google Scholar
• GottliebSSMcCarterRJVogelRA1998Effect of beta-blockade on mortality among high-risk and low risk patients after myocardial infarctionN Engl J Med339489979709041
   PubMed Web of Science ®Google Scholar
• HeidenreichPAMcDonaldKMHastieT1999Meta-analysis of trials comparing betablockers, calcium antagonists, and nitrates for stable anginaJAMA28119273610349897
   PubMed Web of Science ®Google Scholar
• HellerDAAhernFMKozakM2000Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors pf myocardial infarctionAm Heart J1406637111011343
   PubMed Web of Science ®Google Scholar
• [HFSA] Heart Failure Society of America2006Executive Summary: HFSA 2006 comprehensive heart failure practice guidelinesJ Card Fail12103816500578
   PubMed Web of Science ®Google Scholar
• IonnidisJPLauJ1999Pooling research results: benefits and limitations of meta-analysisJt Comm J Qual Improv25462910481815
   PubMedGoogle Scholar
• JNC VI1997The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArch Intern Med1572413469385294
   PubMedGoogle Scholar
• JonasMReicher-ReissHBoykoV1996Usefulness of betablocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery diseaseAm J Cardiol77127378677865
   PubMed Web of Science ®Google Scholar
• KalinowskiLDobruchiLWSzczepanska-KonkelM2003Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive actionCirculation10727475212742996
   PubMed Web of Science ®Google Scholar
• KaroliNARebrovAP2005Chronic obstructive lung disease and coronary heart diseaseKlin Med (Mosk)83726
   PubMedGoogle Scholar
• KendallMJ1997Clinical relevance of pharmacokinetic differences between beta blockersAm J Cardiol8015J19J
   PubMed Web of Science ®Google Scholar
• KennedyHIRosensonRS1995Physician use of beta-adrenergic blocking therapy: a changing perspective [editorial]J Am Coll Cardiol26547527608462
   PubMed Web of Science ®Google Scholar
• KjekshusJGilpinECaliG1990Diabetic patients and beta-blockers after acute myocardial infarctionEur Heart J114350
   PubMed Web of Science ®Google Scholar
• KraussSSpitzEKraussA1984Treatment of hypertension in mild asthmatic patients with atenololAngiology3577386507943
   PubMed Web of Science ®Google Scholar
• LammersJWJFolgerinHTMvan HerwaardenCLA1985Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung diseaseJ Clin Pharmac2020510
   Web of Science ®Google Scholar
• LechatPPackerMChalonS1998Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of placebo-controlled, randomised trialsCirculation981184919743509
   PubMed Web of Science ®Google Scholar
• Macquin-MavierIRoudot-ThoravalFClericiC1988Comparative effects of bisoprolol and acebutolol in smokers with airway obstructionBr J Clin Pharmacol26279842902873
   PubMed Web of Science ®Google Scholar
• ManganoDLayugELWallaceA1996Atenolol reduced mortality and cardiovascular events after noncardiac surgeryN Engl J Med3351713208929262
   PubMed Web of Science ®Google Scholar
• MarciniakTAEllerbeckEFRadfordMJ1998Improving the quality of care for medicare patients with acute myocardial infarction: results from the Cooperative Cardiovasular ProjectJAMA279135179582042
   PubMed Web of Science ®Google Scholar
• McGavinCRWilliamsIP1978The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstructionBr J Dis Chest7232732365214
   PubMedGoogle Scholar
• MoossANHillemanDEMohiuddinSM1994Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapyAnn Pharmacother2870137919552
   PubMed Web of Science ®Google Scholar
• O’MalleyKCoxJPO’BrienE1991Choice of drug treatment for elderly hypertensive patientsAm J Med90Suppl 3A275335
   Google Scholar
• PackerMCoatsAFowlerM2001COPERNICUS: Effect of carvedilol on survival in severe chronic heart failureNEJM3441651811386263
   PubMed Web of Science ®Google Scholar
• PerksWHChatterjeeSSCroxsonRS1978Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstructionBr J Clin Pharmacol51016339932
   PubMed Web of Science ®Google Scholar
• PetersJIGomez-DingerPLFreemanGL2004Use of beta blockers in congestive heart failure (CHF) patients with COPD and/or asthmaChest126921S
   Web of Science ®Google Scholar
• PoldermansDBoersmaEBaxJJ1999The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgeryN Engl J Med34117899210588963
   PubMed Web of Science ®Google Scholar
• QuanSFFensterPEHansonCD1983Suppression of atrial ectopy with intravenous metoprolol in chronic obstructive pulmonary disease patientsJ Clin Pharmacol2334176630583
   PubMed Web of Science ®Google Scholar
• RadackKDeckC1991Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: a meta-analysis of randomized controlled trialsArch Intern Med1511769761679624
   PubMed Web of Science ®Google Scholar
• RanchodAKeetonGRBenatarSR1982The effect of betablockers on ventilatory function in chronic bronchitisS Afr Med J6142347038918
   PubMed Web of Science ®Google Scholar
• ReillyJJSilvermanEKShapiroSD2005Chronic obstructive pulmonary diseaseIn Harrison’s principles of internal medicine textbook.15479
   Google Scholar
• RosensonRS1993The truth about beta-blocker adverse effects F depression, claudication, and lipidsJ Ambulatory Monit616371
   Google Scholar
• SalpeterSOrmistonTSalpeterE2001Cardioselective beta-blocker use in patients with reversible airway disease (Cochrane Review)The Cochrane LibraryOxfordUpdate Software2
   Google Scholar
• SalpeterSOrmistonTSalpeterE2002aCardioselective beta-blocker use in patients with COPD (Cochrane Review)The Cochrane LibraryOxfordUpdate Software2
   Google Scholar
• SalpeterSROrmistonTMSalpeterEE2002bCardioselective β-blockers in patients with reactive airway disease: a meta analysisAnn Intern Med13771525
   PubMed Web of Science ®Google Scholar
• SalpeterSROrmistonTMSalpeterEE2003Cardioselective β-blockers for chronic obstructive pulmonary disease: a meta analysisResp Med971094101
   PubMed Web of Science ®Google Scholar
• SchanningJVilsvikJS1976Beta1-blocker (Practolol) and exercise in patients with chronic obstructive lung diseaseActa Med Scand199614766574
   PubMedGoogle Scholar
• ShigaTWakaumiMYajimaT2002Beta-blocker therapy combined with low dose pimobendan in patients with idiopathic dilated cardiomyopathy and chronic obstructive pulmonary disease: report on two casesCardiovasc Drugs Ther1632596312374905
   PubMed Web of Science ®Google Scholar
• SinclairDJ1979Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitisBr Med J1168369647
   PubMed Web of Science ®Google Scholar
• SorbiniCAGrassiVTantucciC1982Acute effects of oral metoptolol on ventilatory function in patients with chronic obstructive lung diseaseActa Therap8516
   Google Scholar
• StienbeckGAndersonDBachP1992A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmiasN Engl J Med327987921355595
   PubMed Web of Science ®Google Scholar
• TattersfieldAE1986Beta adrenergic antagonists and respiratory diseaseJ Cardiovasc Pharmacol8Suppl 4S3592427850
   PubMed Web of Science ®Google Scholar
• TattersfieldAE1990Respiratory function in the elderly and the effects of beta blockadeCardiovasc Drugs Ther41229321672601
   PubMedGoogle Scholar
• The IPPPSH Collaborative Group1985Cardiovascular risk and risk factors in a randomised trial of treatment based on the beta-blocker oxprenolol: the international prospective primary prevention study in hypertension (IPPPSH)J Hypertension337992
   PubMed Web of Science ®Google Scholar
• The MERIT-HF Study Group2000Effects of controlled-release metoprolol on total mortality, hospitalization, and well-being in patients with heart failureJAMA283129530210714728
   PubMed Web of Science ®Google Scholar
• TiveniusL1976Effects of multiple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung diseaseScand J Respir Dis5741906790561
   PubMedGoogle Scholar
• ViskinSBarronHV1996Beta blockers prevent cardiac death following a myocardial infarction: so why so many infarct survivors discharged without beta blockers? [Editorial]Am J Cardiol7882128857489
   PubMed Web of Science ®Google Scholar
• Von WichertP1982Reversibility of bronchospasm in airway obstructionAm Heart J104446507102530
   PubMed Web of Science ®Google Scholar
• WadworthANMurdochDBrogdenRN1991Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disordersDrugs424685101720383
   PubMed Web of Science ®Google Scholar
• WellsteinAPalmDBelzG1987Reduction of exercise tachycardia in man after propranolol, atenolol, bisoprolol in comarison to beta-adrenoceptor occupancyEur Heart J8Suppl M38
   PubMedGoogle Scholar
• WicklmayrMRettKDietzeG1990Effects of beta-blocking agents on insulin secretion and glucose disposalHorm Metab Res2229331689688
   PubMed Web of Science ®Google Scholar
• WunderlichJMachaHNWudickeH1980Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administrationChest78714206107217
   PubMed Web of Science ®Google Scholar